Search research articles
Contact Us
Filters
Showing results (131-140 of 152) with videos related to
Page
of 16
Sort By:
Reproductive Biomedicine Online
|
February 16, 2024
Comparison of luteal phase and follicular phase in-vitro maturation in women with oocyte maturation abnormalities
Şafak Hatirnaz, Ebru Hatirnaz, Sebati Sinan Urkmez, et al.
Fertility and Sterility
|
August 12, 2008
Cryopreservation of a mother's oocytes for possible future use by her daughter with Turner syndrome: case report
Yariv S Gidoni, Janet Takefman, Hananel E G Holzer, et al.
Reproductive Biomedicine Online
|
September 6, 2023
TUBB8 mutations as a cause of oocyte maturation abnormalities: presentation of oocyte and embryo profiles and novel mutations
Hatirnaz Ebru, Michael H Dahan, Ozlem Sezer, et al.
Human Reproduction (Oxford, England)
|
September 9, 2008
Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles
Weon-Young Son, Jin-Tae Chung, Belen Herrero, et al.
Reproductive Biomedicine Online
|
January 9, 2024
Oocyte in-vitro maturation primed with letrozole-HCG versus FSH-HCG in women with oocyte maturation abnormalities: a retrospective study
Safak Hatirnaz, Ebru Hatirnaz, Sebati Sinan Urkmez, et al.
Reproductive Biomedicine Online
|
February 5, 2009
Feasibility of fertility preservation in young females with Turner syndrome
Nga Man Lau, Jack Yu Jen Huang, Suzanne MacDonald, et al.
Journal of Assisted Reproduction and Genetics
|
April 23, 2005
A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment
Seang Lin Tan, Timothy J Child, Anthony P Cheung, et al.
Fertility and Sterility
|
June 3, 2008
Live birth after vitrification of in vitro matured human oocytes
Ri-Cheng Chian, Lucy Gilbert, Jack Y J Huang, et al.
Human Reproduction (Oxford, England)
|
June 17, 2008
A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles
Weon-Young Son, Jin-Tae Chung, Ri-Cheng Chian, et al.
International Journal of Fertility & Sterility
|
July 8, 2024
Preimplantation Genetic Testing for Aneuploidy in <i>In Vitro</i> Fertilization Using Comprehensive Chromosome Screening: A Systematic Review and Meta-Analysis
Omur Taskin, Alyssa Hochberg, Justin Tan, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 152) with videos related to
Sort By:
Page
of 16
Reproductive Biomedicine Online
|
February 16, 2024
Comparison of luteal phase and follicular phase in-vitro maturation in women with oocyte maturation abnormalities
Şafak Hatirnaz, Ebru Hatirnaz, Sebati Sinan Urkmez, et al.
Fertility and Sterility
|
August 12, 2008
Cryopreservation of a mother's oocytes for possible future use by her daughter with Turner syndrome: case report
Yariv S Gidoni, Janet Takefman, Hananel E G Holzer, et al.
Reproductive Biomedicine Online
|
September 6, 2023
TUBB8 mutations as a cause of oocyte maturation abnormalities: presentation of oocyte and embryo profiles and novel mutations
Hatirnaz Ebru, Michael H Dahan, Ozlem Sezer, et al.
Human Reproduction (Oxford, England)
|
September 9, 2008
Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles
Weon-Young Son, Jin-Tae Chung, Belen Herrero, et al.
Reproductive Biomedicine Online
|
January 9, 2024
Oocyte in-vitro maturation primed with letrozole-HCG versus FSH-HCG in women with oocyte maturation abnormalities: a retrospective study
Safak Hatirnaz, Ebru Hatirnaz, Sebati Sinan Urkmez, et al.
Reproductive Biomedicine Online
|
February 5, 2009
Feasibility of fertility preservation in young females with Turner syndrome
Nga Man Lau, Jack Yu Jen Huang, Suzanne MacDonald, et al.
Journal of Assisted Reproduction and Genetics
|
April 23, 2005
A randomized, double-blind, multicenter study comparing a starting dose of 100 IU or 200 IU of recombinant follicle stimulating hormone (Puregon) in women undergoing controlled ovarian hyperstimulation for IVF treatment
Seang Lin Tan, Timothy J Child, Anthony P Cheung, et al.
Fertility and Sterility
|
June 3, 2008
Live birth after vitrification of in vitro matured human oocytes
Ri-Cheng Chian, Lucy Gilbert, Jack Y J Huang, et al.
Human Reproduction (Oxford, England)
|
June 17, 2008
A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles
Weon-Young Son, Jin-Tae Chung, Ri-Cheng Chian, et al.
International Journal of Fertility & Sterility
|
July 8, 2024
Preimplantation Genetic Testing for Aneuploidy in <i>In Vitro</i> Fertilization Using Comprehensive Chromosome Screening: A Systematic Review and Meta-Analysis
Omur Taskin, Alyssa Hochberg, Justin Tan, et al.
Page
of 16